Pancreatic Cancer Research

ResearcherNebraska Medical CenterActive in the last 2 years

Zahraa Wajih Alsafwani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-1795-3598; OpenAlex author ID A5029815874. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 5 papers

Papers 9

  1. Targeting the DDX3/PAF1 axis enhances chemotherapy efficacy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2026.218276↗
  2. Unique N-glycoproteomics and phosphoproteomics of mucins predict clinical outcomes in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2026.218653↗
  3. SLC22A3/OCT3 drives serotonin-mediated stemness in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2026.117387↗
  4. Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis. Co-author DOI 10.1038/s41388-026-03896-5↗
  5. Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer. First author DOI 10.1053/j.gastro.2026.04.041↗
  6. Targeting cancer-associated fibroblast-driven LIF/LIFR axis improves the therapeutic efficacy of gemcitabine and nab-paclitaxel in pancreatic cancer. Co-author DOI 10.1038/s41698-025-01046-w↗
  7. Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LAMA5/ITGA4 Axis. Co-author DOI 10.1053/j.gastro.2023.12.018↗
  8. PAF1/HIF1α axis rewires the glycolytic metabolism to fuel aggressiveness of pancreatic cancer. Co-author DOI 10.1186/s40170-024-00354-2↗
  9. MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma. Co-author DOI 10.3389/fonc.2023.1073820↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Surinder K. Batra · 9 shared papers, 2023–2026 · strength 2.16
  2. Moorthy Palanimuthu Ponnusamy · 7 shared papers, 2023–2026 · strength 1.49
  3. Palanisamy Nallasamy · 5 shared papers, 2024–2026 · strength 1.13
  4. Sanchita Rauth · 5 shared papers, 2024–2026 · strength 1.10
  5. Jesse L. Cox · 5 shared papers, 2024–2026 · strength 1.08
  6. Namita Bhyravbhatla · 4 shared papers, 2023–2026 · strength 1.05
  7. Saravanakumar Marimuthu · 4 shared papers, 2024–2026 · strength 0.94
  8. Venkatesh Varadharaj · 3 shared papers, 2026 · strength 0.71
  9. Sushil Kumar K · 2 shared papers, 2023–2026 · strength 0.60
  10. Rama Krishna Nimmakayala · 3 shared papers, 2023–2024 · strength 0.57
  11. Ashu Shah · 2 shared papers, 2026 · strength 0.49
  12. Kavita B. Mallya · 2 shared papers, 2026 · strength 0.48
  13. Parthasarathy Seshacharyulu · 2 shared papers, 2025–2026 · strength 0.48
  14. Mokenge Peter Malafa · 2 shared papers, 2025–2026 · strength 0.45
  15. Nivedeta Krishna Kumar · 2 shared papers, 2026 · strength 0.45
  16. Kirtana Arikath BS · 2 shared papers, 2026 · strength 0.45
  17. Geoffrey A. Talmon · 2 shared papers, 2026 · strength 0.45
  18. Subodh M. Lele · 2 shared papers, 2024–2026 · strength 0.44
  19. Frank Leon · 2 shared papers, 2024–2026 · strength 0.39
  20. Ayoola O. Ogunleye · 2 shared papers, 2024 · strength 0.39
  21. Maneesh Jain · 2 shared papers, 2023–2025 · strength 0.38
  22. Krystal Villalobos-Ayala · 1 shared paper, 2026 · strength 0.24
  23. Pranita Atri · 1 shared paper, 2026 · strength 0.24
  24. Imran Khan · 1 shared paper, 2026 · strength 0.24
  25. Margaret A. Park · 1 shared paper, 2026 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.